• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性嗜睡症的精准医学

Precision Medicine for Idiopathic Hypersomnia.

作者信息

Arnulf Isabelle, Leu-Semenescu Smaranda, Dodet Pauline

机构信息

National Reference Center for Rare Hypersomnias, Pitie-Salpetriere University Hospital, APHP, and Sorbonne University, 47-83 Boulevard de l'Hôpital, Paris 75013, France.

National Reference Center for Rare Hypersomnias, Pitie-Salpetriere University Hospital, APHP, and Sorbonne University, 47-83 Boulevard de l'Hôpital, Paris 75013, France.

出版信息

Sleep Med Clin. 2019 Sep;14(3):333-350. doi: 10.1016/j.jsmc.2019.05.007.

DOI:10.1016/j.jsmc.2019.05.007
PMID:31375202
Abstract

Idiopathic hypersomnia (IH) is characterized by excessive daytime sleepiness despite normal or prolonged sleep. IH is distinguished from narcolepsy by the female predominance, severe morning inertia, continuous drowsiness (rather than sleep attacks), unrefreshing naps, absence of cataplexy, sleep onset in REM periods, and hypocretin deficiency. In IH, the multiple sleep latency test demonstrates low sensitivity, specificity, and reproducibility, compared with prolonged sleep monitoring. In some IH cases, an endogenous hypnotic peptide stimulating GABA receptors during wakefulness is suspected, which are improved by anti-GABA drugs. The benefits of modafinil, sodium oxybate, mazindol, and pitolisant were found in mostly retrospective studies.

摘要

特发性嗜睡症(IH)的特征是尽管睡眠正常或延长,但白天仍过度嗜睡。IH与发作性睡病的区别在于女性居多、严重的晨起惯性、持续嗜睡(而非睡眠发作)、小睡后无恢复感、无猝倒、快速眼动期睡眠起始以及下丘脑分泌素缺乏。与延长睡眠监测相比,在IH中多次睡眠潜伏期测试显示出低敏感性、特异性和可重复性。在一些IH病例中,怀疑存在一种在清醒时刺激GABA受体的内源性催眠肽,抗GABA药物可改善这种情况。莫达非尼、羟丁酸钠、马吲哚和匹莫林的疗效大多在回顾性研究中被发现。

相似文献

1
Precision Medicine for Idiopathic Hypersomnia.特发性嗜睡症的精准医学
Sleep Med Clin. 2019 Sep;14(3):333-350. doi: 10.1016/j.jsmc.2019.05.007.
2
Precision Medicine for Idiopathic Hypersomnia.特发性发作性睡病的精准医学
Sleep Med Clin. 2022 Sep;17(3):379-398. doi: 10.1016/j.jsmc.2022.06.016. Epub 2022 Sep 8.
3
Medications for daytime sleepiness in individuals with idiopathic hypersomnia.特发性嗜睡症患者日间嗜睡的药物治疗。
Cochrane Database Syst Rev. 2021 May 25;5(5):CD012714. doi: 10.1002/14651858.CD012714.pub2.
4
Idiopathic Hypersomnia and Other Hypersomnia Syndromes.特发性嗜睡症和其他嗜睡症综合征。
Neurotherapeutics. 2021 Jan;18(1):20-31. doi: 10.1007/s13311-020-00919-1.
5
Update on treatment for idiopathic hypersomnia.特发性嗜睡症的治疗进展
Expert Opin Investig Drugs. 2018 Feb;27(2):187-192. doi: 10.1080/13543784.2018.1417385. Epub 2018 Jan 3.
6
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.羟丁酸钠、莫达非尼及联合治疗对伴或不伴猝倒发作的发作性睡病患者日间过度嗜睡的影响
Sleep Med. 2016 Aug;24:57-62. doi: 10.1016/j.sleep.2016.07.010. Epub 2016 Aug 22.
7
Idiopathic Hypersomnia.特发性嗜睡症
Sleep Med Clin. 2017 Sep;12(3):331-344. doi: 10.1016/j.jsmc.2017.03.009. Epub 2017 Jun 16.
8
Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study.莫达非尼治疗无长睡眠时相的特发性嗜睡症患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照、平行分组比较研究。
Sleep Med. 2021 Apr;80:315-321. doi: 10.1016/j.sleep.2021.01.018. Epub 2021 Jan 20.
9
Sodium oxybate improves excessive daytime sleepiness in narcolepsy.羟丁酸钠可改善发作性睡病患者的日间过度嗜睡症状。
Sleep. 2006 Jul;29(7):939-46. doi: 10.1093/sleep/29.7.939.
10
A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia.特发性嗜睡症的药理学和非药理学干预措施的证据范围综述。
J Clin Sleep Med. 2024 Oct 1;20(10):1685-1704. doi: 10.5664/jcsm.11250.

引用本文的文献

1
A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy.一项以患者为中心的临床试验设计,旨在全面评估低钠羟丁酸钠在发作性睡病或特发性过度睡眠患者中的疗效。
Neurol Ther. 2025 Jun 9. doi: 10.1007/s40120-025-00745-7.
2
Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatment.关于特发性嗜睡症病理生理学的当前知识以及低钠羟丁酸钠治疗的潜在作用机制。
J Clin Sleep Med. 2025 Jul 1;21(7):1245-1260. doi: 10.5664/jcsm.11566.
3
Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review.
特发性嗜睡症的诊断挑战与负担:一项系统文献综述
Sleep Adv. 2024 Aug 16;5(1):zpae059. doi: 10.1093/sleepadvances/zpae059. eCollection 2024.
4
Genome-wide association study of idiopathic hypersomnia in a Japanese population.日本人群特发性发作性睡病的全基因组关联研究。
Sleep Biol Rhythms. 2021 Oct 12;20(1):137-148. doi: 10.1007/s41105-021-00349-2. eCollection 2022 Jan.
5
Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate.低钠羟丁酸钠对发作性睡病和特发性嗜睡症的长期治疗
Nat Sci Sleep. 2023 Aug 19;15:663-675. doi: 10.2147/NSS.S412793. eCollection 2023.
6
Idiopathic Hypersomnia: Neurobiology, Diagnosis, and Management.特发性嗜睡症:神经生物学、诊断与治疗。
CNS Drugs. 2023 Apr;37(4):305-322. doi: 10.1007/s40263-023-00998-6. Epub 2023 Apr 18.
7
Pharmacological Characterization of Purified Full-Length Dopamine Transporter from .从. 中纯化的全长多巴胺转运蛋白的药理学特性
Cells. 2022 Nov 28;11(23):3811. doi: 10.3390/cells11233811.
8
Central Disorders of Hypersomnolence: Association with Fatigue, Depression and Sleep Inertia Prevailing in Women.中枢性过度嗜睡障碍:与女性中普遍存在的疲劳、抑郁和睡眠惯性的关联。
Brain Sci. 2022 Nov 3;12(11):1491. doi: 10.3390/brainsci12111491.
9
Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia.低钠羟丁酸钠在成年特发性发作性睡病患者3期临床研究开放标签滴定期的疗效与安全性
Nat Sci Sleep. 2022 Oct 26;14:1901-1917. doi: 10.2147/NSS.S369122. eCollection 2022.
10
Antibiotics and mental health: The good, the bad and the ugly.抗生素与心理健康:好坏参半。
J Intern Med. 2022 Dec;292(6):858-869. doi: 10.1111/joim.13543. Epub 2022 Jul 12.